(Q38231235)

31 August 2017

0 references

Ketamine administration in depressive disorders: a systematic review and meta-analysis (English)

1 reference

Jean-Arthur Micoulaud-Franchi

31 August 2017

1 reference

1 reference

Guillaume Fond

1

0 references

object named as

Jean-Arthur Micoulaud-Franchi

7

0 references

Marion Leboyer

object named as

Marion Leboyer

12

0 references

Christophe Lançon

5

object named as

Christophe Lançon

1 reference

31 August 2017

8

Raphaelle Richieri

1 reference

31 August 2017

Anderson Loundou

2

1 reference

31 August 2017

Corentin Rabu

3

1 reference

31 August 2017

Alexandra Macgregor

4

1 reference

31 August 2017

Marie Brittner

6

1 reference

31 August 2017

Philippe Courtet

9

1 reference

31 August 2017

Mocrane Abbar

10

1 reference

31 August 2017

Matthieu Roger

11

1 reference

31 August 2017

Laurent Boyer

13

1 reference

31 August 2017

publication date

20 July 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

231

1 reference

31 August 2017

issue

18

1 reference

31 August 2017

page(s)

3663-3676

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-014-3664-5

31 August 2017

exact match

0 references

cites work

Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Ketamine (“Ketalar”): A Safer Anaesthetic for ECT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Grand challenges in global mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Ketamine As an Anaesthetic for Ect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Levels of evidence: Taking Neurology to the next level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Intramuscular ketamine in acute depression: A report on two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Small-dose ketamine improves the postoperative state of depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

21 January 2018

Ketamine use: a review

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-014-3664-5

Effects of ketamine on in vivo cardiac sympathetic nerve endings

21 January 2018

1 reference

12 December 2020

Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.

1 reference

12 December 2020

Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression

1 reference

12 December 2020

Systematic meta-analyses and field synopsis of genetic association studies of violence and aggression

1 reference

12 December 2020

Treatment-resistant depression.

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophrenia

1 reference

12 December 2020

10.1007/S00213-014-3664-5

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1008340109

0 references

1 reference